Cardiac MRI in Ischemic Stroke Study (CaMriSS)

Charité University Medicine Berlin

Status: Completed

Conditions: Stroke

Study type: Observational

Funder types: Other

Identifiers

NCT01917955

EA4/073/10 (Other Identifier)

CaMriSS_CSB

Details and patient eligibility

About

The purpose of this prospective single-center trial is to compare the safety and diagnostic value of contrast medium-enhanced cardiac magnetic resonance imaging and transesophageal echocardiography in patients with acute ischemic stroke.

Full description

Primary safety objective: Contrast medium-enhanced cardiac magnetic resonance imaging is safe in patients with acute ischemic stroke. Primary outcome: The diagnostic value of contrast medium-enhanced cardiac magnetic resonance imaging is comparable to transesophageal echocardiography in patients with acute ischemic stroke.

Enrollment: 103 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with acute ischemic stroke detected by brain magnetic resonance imaging.

Exclusion criteria

• Known atrial fibrillation or cardiac source of embolism
• Severe aphasia
• Acute infection or chronic inflammation
• Severe arteriosclerosis or stenosis of brain-supplying arteries
• Contraindications for magnetic resonance imaging or transesophageal echocardiography.